IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

LYTENAVA Receives FDA Approval for Wet AMD — Jul 24, 2026Outlook Therapeutics has won FDA approval for LYTENAVA (bevacizumab-vikg), making it the first and only ophthalmic bevacizumab formulation approved for treating wet AMD in the United States and a potential new standard of care developed specifically for the eye. The approval follows a lengthy regulatory history and positions LYTENAVA with anticipated market exclusivity under the BPCIA while signaling a major milestone for retina care.

Gait Study Context Expands to Dementia Risk ResearchHealth — Aug 25, 2026New research across several fields suggests multiple early signals and risk factors for dementia and Alzheimer's, from subtle gait changes and sleep micro-awakenings to retinal blood-vessel damage and midlife shifts in brain immune cells, all aimed at earlier detection and prevention. At the same time, public awareness of modifiable risk factors remains low in the UK, underscoring the need for education alongside biomedical insights.